AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
4
Halozyme Therapeutics
HALO
5
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -8.78%101.68M | -4.20%26.97M | -9.51%24.88M | -4.70%24.62M | -15.91%25.22M | -11.17%111.47M | -8.66%28.15M | -13.07%27.5M | -18.62%25.84M | -4.17%29.99M |
Operating revenue | -8.78%101.68M | -4.20%26.97M | -9.51%24.88M | -4.70%24.62M | -15.91%25.22M | -11.17%111.47M | -8.66%28.15M | -13.07%27.5M | -18.62%25.84M | -4.17%29.99M |
Cost of revenue | -8.54%39.42M | -7.03%10.37M | -9.66%9.53M | -6.35%9.4M | -10.93%10.12M | -8.65%43.1M | -8.38%11.16M | -11.14%10.55M | -8.40%10.04M | -6.73%11.36M |
Gross profit | -8.93%62.26M | -2.34%16.59M | -9.42%15.35M | -3.66%15.22M | -18.94%15.1M | -12.69%68.37M | -8.85%16.99M | -14.22%16.95M | -24.01%15.8M | -2.55%18.63M |
Operating expense | -4.40%40.69M | -0.43%10.83M | -2.04%9.88M | -3.31%9.94M | -11.31%10.04M | -9.99%42.57M | -0.87%10.88M | -9.25%10.09M | -23.58%10.28M | -3.63%11.32M |
Selling and administrative expenses | -5.36%36.62M | -1.30%9.74M | -2.99%8.82M | -4.45%8.96M | -12.13%9.11M | -9.07%38.7M | 1.12%9.86M | -9.18%9.1M | -23.52%9.37M | -1.58%10.37M |
-Selling and marketing expense | -2.16%20.54M | -0.47%5.34M | -1.64%4.98M | -2.50%4.87M | -3.97%5.35M | -4.28%20.99M | -0.45%5.36M | -3.84%5.06M | -9.13%5M | -3.63%5.57M |
-General and administrative expense | -9.15%16.09M | -2.29%4.4M | -4.68%3.85M | -6.68%4.08M | -21.61%3.76M | -14.16%17.71M | 3.04%4.5M | -15.08%4.04M | -35.24%4.37M | 0.93%4.79M |
Research and development costs | 5.17%4.07M | 7.99%1.1M | 6.65%1.06M | 8.49%984K | -2.51%931K | -18.28%3.87M | -16.82%1.01M | -9.90%992K | -24.23%907K | -21.46%955K |
Operating profit | -16.39%21.57M | -5.74%5.76M | -20.28%5.47M | -4.31%5.28M | -30.77%5.06M | -16.82%25.8M | -20.27%6.11M | -20.62%6.86M | -24.80%5.52M | -0.81%7.31M |
Net non-operating interest income expense | 34.00%2.28M | 3.07%537K | 16.73%586K | 53.79%609K | 94.31%546K | 877.01%1.7M | 327.05%521K | 1,468.75%502K | 3,500.00%396K | 3,022.22%281K |
Non-operating interest income | 34.00%2.28M | 3.07%537K | 16.73%586K | 53.79%609K | 94.31%546K | 877.01%1.7M | 327.05%521K | 1,468.75%502K | 3,500.00%396K | 3,022.22%281K |
Other net income (expense) | -593.48%-227K | -687.50%-188K | 151.22%21K | -229.17%-31K | -193.55%-29K | 121.80%46K | -80.37%32K | 80.48%-41K | 117.39%24K | 219.23%31K |
Other non- operating income (expenses) | -593.48%-227K | -687.50%-188K | 151.22%21K | -229.17%-31K | -193.55%-29K | 121.80%46K | -80.37%32K | 80.48%-41K | 117.39%24K | 219.23%31K |
Income before tax | -14.24%23.62M | -8.33%6.11M | -17.01%6.08M | -1.35%5.86M | -26.82%5.58M | -11.08%27.55M | -16.17%6.67M | -13.51%7.32M | -17.66%5.94M | 3.66%7.62M |
Income tax | -16.38%5.71M | -19.05%1.47M | -15.29%1.48M | -0.29%1.39M | -26.74%1.38M | -6.85%6.83M | 2.37%1.81M | -9.25%1.75M | -20.74%1.39M | -0.11%1.88M |
Net income | -13.54%17.92M | -4.33%4.65M | -17.55%4.6M | -1.67%4.47M | -26.84%4.2M | -12.40%20.72M | -21.48%4.86M | -14.76%5.57M | -16.67%4.55M | 4.95%5.74M |
Net income continuous Operations | -13.54%17.92M | -4.33%4.65M | -17.55%4.6M | -1.67%4.47M | -26.84%4.2M | -12.40%20.72M | -21.48%4.86M | -14.76%5.57M | -16.67%4.55M | 4.95%5.74M |
Minority interest income | -130.23%-99K | -8.82%-37K | -950.00%-21K | -266.67%-22K | -1,800.00%-19K | -243.33%-43K | -1,800.00%-34K | -100.00%-2K | -160.00%-6K | -105.26%-1K |
Net income attributable to the parent company | -13.24%18.01M | -4.23%4.68M | -17.20%4.62M | -1.32%4.5M | -26.52%4.22M | -12.10%20.76M | -20.90%4.89M | -14.74%5.58M | -16.40%4.56M | 5.34%5.74M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -13.24%18.01M | -4.23%4.68M | -17.20%4.62M | -1.32%4.5M | -26.52%4.22M | -12.10%20.76M | -20.90%4.89M | -14.74%5.58M | -16.40%4.56M | 5.34%5.74M |
Basic earnings per share | -13.59%1.78 | -6.12%0.46 | -16.36%0.46 | 0.00%0.45 | -26.32%0.42 | -11.97%2.06 | -19.67%0.49 | -15.38%0.55 | -16.67%0.45 | 5.56%0.57 |
Diluted earnings per share | -13.59%1.78 | -6.12%0.46 | -16.36%0.46 | 0.00%0.45 | -26.32%0.42 | -11.97%2.06 | -19.67%0.49 | -15.38%0.55 | -16.67%0.45 | 5.56%0.57 |
Dividend per share | 3.05%1.35 | 3.03%0.34 | 3.03%0.34 | 3.03%0.34 | 3.13%0.33 | 3.97%1.31 | -48.44%0.33 | 3.13%0.33 | 10.00%0.33 | 0.32 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |